Table 1.
Markers for blood vessels (expressed as a percentage of the total chamber area, mean ± SD) in AVL (above) and no AVL controls (below).
| 7 days | 14 days | 21 days | 28 days | |
|---|---|---|---|---|
| α-SMA (%) |
1.06 ± 0.38 (0.27 ± 0.12) |
6.32 ± 2.64 (2.21 ± 0.07) |
7.89 ± 2.11 (4.35 ± 1.77) |
12.35 ± 4.29 (3.58 ± 3.02) |
|
p-value (AVL vs. no AVL) |
0.1029 | 0.0208 | 0.0231 | 0.0037 |
| CD31 (%) |
3.27 ± 3.75 (0.90 ± 0.35) |
8.42 ± 2.52 (0.91 ± 0.35) |
12.82 ± 3.27 (2.86 ± 2.78) |
18.45 ± 5.83 (2.49 ± 0.85) |
|
p-value (AVL vs. no AVL) |
0.3159 | 0.0041 | 0.0219 | 0.0002 |
| Laminin (%) |
1.37 ± 0.44 (0.85 ± 0.58) |
9.60 ± 1.63 (3.76 ± 0.74) |
13.02 ± 1.47 (5.71 ± 1.00) |
17.55 ± 3.43 (1.85 ± 0.68) |
|
p-value (AVL vs. no AVL) |
0.2815 | 0.0099 | 0.0035 | 0.0001 |
P-values are given below for t-test comparisons between AVL and controls.